Former Amherst Pediatrician Pleads Guilty To Making False Statements To DEA
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Former Amherst Pediatrician Pleads Guilty To Making False Statements To DEA

Former Amherst Pediatrician Pleads Guilty To Making False Statements To DEA

Junio 21, 2011
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Kristen Govostes
Phone Number: (617) 557-2100

CONCORD, NH. - James A. Canfield, who formerly practiced medicine as a pediatrician in Amherst, New Hampshire, pled guilty in United States District Court for the District of New Hampshire to making materially false statements to the Drug Enforcement (DEA), announced Steven W. Derr, Special Agent in Charge of the Drug Enforcement Administration for New England and United States Attorney John P. Kacavas.

The DEA conducted an investigation of Canfield’s purchase of more than 6,000 (20) milligram tablets of Methylphenidate, a schedule II controlled substance used to treat attention deficit disorder, between November 2006, and February 2009. Canfield told DEA agents that he purchased approximately 400 Methylphenidate tablets every 2 months to provide to a charity that sent the tablets to an orphanage in Romania for children with attention deficit disorders. He also supplied the DEA with prescription labels that he said had been pre-printed for use with the drugs to be shipped to Romania. The DEA investigation concluded that Canfield had not sent any Methylphenidate to the charity in question.

Canfield admitted that he had lied to the DEA and that he had not sent any drugs to the charity. He is facing a maximum sentence of five years in prison and a $250,000 fine and is scheduled to be sentenced on September 30, 2011.

In addition to his guilty plea, Canfield also has agreed to pay $18,000.00 to resolve allegations that he violated the DEA’s recordkeeping regulations. Canfield entered into a civil settlement to resolve allegations that he obtained quantities of Methylphenidate on approximately 17 different occasions between November 2006 and February 2009 without properly documenting the receipt of the drugs, maintaining an inventory of the drugs, maintaining records regarding the dispensing or other disposition of the drugs, and without admitting any liability. Federal regulations require individuals who are registered with the DEA to maintain accurate records of controlled substances that they receive or dispense. Canfield has voluntarily surrendered his license to practice medicine and his DEA Certificate of Registration.

The investigation was conducted by the Drug Enforcement Administration.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Jarod Forget Special Agent in Charge - New England
@DEANewEngland
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Quiénes somos
  • Recursos
Back
  • Sobre la DEA
  • Mission
  • Nuestra historia
  • Divisiones Nacionales
  • DEA Museum
  • Wall of Honor
  • Contáctenos
Back
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Ley de Libertad de Información
  • Publications
  • Galerías Multimedia
  • Programa de Asistencia a Testigos para Víctimas
Back
  • Fee Waiver
Back
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español